Stangl, Stefan
Nguyen, Nghia Trong
Brosch-Lenz, Julia
Šimeček, Jakub
Weber, Wolfgang A.
Kossatz, Susanne
Notni, Johannes http://orcid.org/0000-0002-3964-3391
Funding for this research was provided by:
Sächsische Aufbaubank (project INTRA, #100685203)
Technische Universität München
Article History
Received: 27 February 2024
Accepted: 26 April 2024
First Online: 8 May 2024
Declarations
:
: Procedures involving laboratory mice and their care were conducted in conformity with institutional guidelines and with approval from the responsible local authorities (Regierung von Oberbayern, ROB-55.2–2532.Vet_02-19–62, ROB-55.2–2532.Vet_02-15–216 and ROB-55.2–2532.Vet_02-21–127).
: N/a.
: N/a.
: J.N. is an inventor of patent applications related to αvβ6-integrin binding peptide conjugates and <sup>68</sup>Ga-Trivehexin. J.N. and J.Š. are CSO and CEO, respectively, and co-founders of TRIMT GmbH (Radeberg, Germany) who has licensed IP from TU Munich. J.N. is furthermore a member of the Scientific Advisory Board of Radiopharm Theranostics LLC (Carlton, Australia) who has licensed IP from TRIMT GmbH. S.K. received research funding from TRIMT GmbH. W.A.W. is an editor of this journal.